Role of IL-5 in the development of allergen-induced airway hyperresponsiveness

International Archives of Allergy and Immunology

Volumn 120, Issue 1, 1999, Pages 8-16

  Hamelmann, Eckard ^a,b   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Antibody, monoclonal; Eosinophils; IL 5; Mice, cytokine deficient

Indexed keywords

ANTIBODY; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 5 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; EOSINOPHIL; HUMAN; INFLAMMATION; KNOCKOUT MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SENSITIZATION;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EOSINOPHILIA; EOSINOPHILS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-5; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-5;

EID: 0032829247     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024215     Document Type: Article

References (100)

1. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop report. National Heart, Lung and Blood Institute Publication No. 95-3659, January 1995.
2. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
3. Gleich GJ: The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Immunol 1990;85:422-436.
4. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-507.
5. Corrigan CJ, Kay AB: CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis 1990;141:970-977.
6. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
7. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/ macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
8. Kay AB, Durham SR: T-lymphocytes, allergy and asthma. Clin Exp Allergy 1991;1:17-21.
9. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AM, Schwartz LB, Durham SR, Jeffery PK, Kay AB: Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-674.
10. Kay AB: Eosinophils and asthma. N Engl J Med 1991;324:1514-1515.
11. Djukanovic R, Lai CK, Wilson JW, Britten KM, Wilson SJ, Roche WR, Howarth PH, Holgate ST: Bronchial mucosal manifestations of atopy: A comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-544.
12. Hessel EM, Van Oosterhout AJ, Van Ark I, Van Esch B, Hofman G, Van Loveren H, Savelkoul HF, Nijkamp FP: Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am. J Respir. Cell Mol. Biol. 1997; 16: 325-334.
13. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA: Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-224.
14. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167: 43-56.
15. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K: Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-1742.
16. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB: Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407-1413.
17. Beasley R, Roche WR, Roberts JA, Holgate ST: Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989;139:806-817.
18. Ohashi Y, Motojima S, Fukuda T, Makino S: Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992;145:1469-1476.
19. Durham SR, Loegering DA, Dunnette S, Gleich GJ, Kay AB: Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989;84:931-936.
20. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM: Interleukin-4, but not Interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183:109-117.
21. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG: Interleukin-5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
22. Drazen JM, Arm JP, Austen KF: Sorting out the cytokines of asthma. J Exp Med 1996; 183:1-5.
23. Yokota T, Coffman RL, Hagiwara H, Rennick DM, Takebe Y, Yokota K, Gemmell L, Shrader B, Yang G, Meyerson P, et al: Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: Relationship to interleukin. Proc Natl Acad Sci USA 1987;84:7388-7392.
24. Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt-Lindqvist S, Takahashi M, et al: Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 1986;324:70-73.
25. Campbell HD, Sanderson CJ, Wang Y, Hort Y, Martinson ME, Tucker WQ, Stellwagen A, Strath M, Young IG: Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor. Comparison with other eosinophilopoietic lymphokines and identity with interleukin-5. Eur J Biochem 1988;174:345-352.
26. Campbell HD, Tucker WQ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG: Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin-5). Proc Natl Acad Sci USA 1987;84: 6629-6633.
27. Nakajima H, Iwamoto I, Tomoe S, Matsumura R, Tomioka H, Takatsu K, Yoshida S: CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146: 374-377.
28. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB: Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-1546.
29. Coffman RL, Seymour BW, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HF, Finkelman FD, Bond MW, et al: The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 1988;102:5-28.
30. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136: 2348-2357.
31. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-480.
32. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989;339:64-67.
33. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron A, Capron M: Interleukin-5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179: 703-708.
34. Takeda K, Hamelmann E, Joetham A, Irvin CG, Shultz LD, Gelfand EW: Development of eosinophilic airway Inflammation and airway hyperresponsiveness (AHR) in allergen sensitized mast cell deficient mice. J Exp Med 1997;186:449-454.
35. Hamelmann E, Oshiba A, Schwarze J, Bradley KL, Loader JE, Larsen GL, Gelfand EW: Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 1997;16:674-682.
36. Hamelmann E, Gelfand EW: The role of cytokines in the development of allergen-induced airway hyperresponsiveness. Allergy Clin Immunol Int 1998;10:59-63.
37. Takaki S, Murata Y, Kitamura T, Miyajima A, Tominaga A, Takatsu K: Reconstitution of the functional receptors for murine and human interleukin-5. J Exp Med 1993;177:1523-1529.
38. Takaki S, Tominaga A, Hitoshi Y, Mita S, Sonoda E, Yamaguchi N, Takatsu K: Molecular cloning and expression of the murine interleukin-5 receptor. EMBO J 1990;9:4367-4374.
39. Murata Y, Takaki S, Migita M, Kikuchi Y, Tominaga A, Takatsu K: Molecular cloning and expression of the human interleukin-5 receptor. J Exp Med 1992;175:341-351.
40. Adachi T, Alam R: The mechanism of IL-5 signal transduction. Am J Physiol 1998;275: C623-633.
41. Sato S, Katagiri T, Takaki S, Kikuchi Y, Hitoshi Y, Yonehara Y, Tsukada S, Kitamura D, Watanabe T, Witte O, et al: IL-5 receptor-mediated tyrosine phosphorylalion of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994; 180:2101-2111.
42. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-3908.
43. Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L: Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7: 631-636.
44. Schweizer RC, Welmers BA, Raaijmakers JA, Zanen P, Lammers JW, Koenderman L: RANTES-and interleukin-8-induced responses in normal human eosinophils: Effects of priming with interleukin-5. Blood 1994;83: 3697-3704.
45. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB: Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-2959.
46. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L: Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993;91: 1198-1205.
47. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71: 258-265.
48. Tominaga A, Takaki S, Koyama N, Katoh S, Malsumoto R, Migita M, Hitoshi Y, Hosoya Y, Yamauchi S, Kanal Y, et al: Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J. Exp. Med. 1991;173:429-437.
49. Dent LA, Strath M, Mellor AL, Sanderson CL: Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 1990;172:1425-1431.
50. Walker C, Virchow JC Jr, Bruijnzeel PL, Blaser K: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 1991;146:1829-1835.
51. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, Durham SR, Kay AB: CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993;147:540-547.
52. Walker C, Kaegi MK, Braun P, Blaser K: Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88:935-942.
53. Till S, Dickason R, Huston D, Humbert M, Robinson D, Larche M, Durham S, Kay AB, Corrigan C: IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: Relationship to expression of allergic disease. J Allergy Clin Immunol 1997;99:563-569.
54. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997;156:704-708.
55. Shi HZ, Xiao CQ, Zhong D, Qin SM, Liu Y, Liang GR, Xu H, Chen YQ, Long XM, Xie ZF: Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 1998;157:204-209.
56. Shi H, Qin S, Huang G, Chen Y, Xiao C, Xu H, Liang G, Xie Z, Qin X, Wu J, Li G, Zhang C: Infiltration of eosinophils into the asthmatic airways caused by interleukin-5. Am J Respir Cell Mol Biol 1997;16:220-224.
57. Coyle AJ, Ackerman SJ, Irvin CG: Cationic proteins induce airway hyperresponsiveness dependent on charge interactions. Am Rev Respir Dis 1993;147:896-900.
58. Coyle AJ, Mitzner W, Irvin CG: Cationic proteins alter smooth muscle function by an epithelium-dependent mechanism. J Appl Physiol 1993;74:1761-1768.
59. Jacoby DB, Gleich GJ, Fryer AD: Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest 1993;91: 1314-1318.
60. Gundel RH, Letts LG, Gleich GJ: Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991;87:1470-1473.
61. Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich GJ, Lee JJ, Gelfand EW: Anti-interleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997; 155:819-825.
62. Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA, Larsen GL, Gelfand EW: Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a murine model of airway sensitizaTion. J Exp Med 1996;183:1719-1730.
63. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156: 766-775.
64. Hamelmann E, Takeda K, Gelfand EW: Animal models of airway hyperresponsiveness. Curr Probl Immunol 1999, in press.
65. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, Brenneise IE, Horton MA, Haczku A, Gelfand EW, Leikauf GD, Lee NA: Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-2156.
66. Hamelmann E, Schwarze J, Oshiba A, Bradley K, Loader J, Larsen GL, Coffman RL, Gelfand EW: Anti interleukin-5 but not anti-IgE prevents development of airway eosinophilia and airway hyperresponsiveness in sensitized mice. Am J Respir Crit Care Med 1999, in press.
67. Eum SY, Haile S, Lefort J, Huerre M, Vargaftig BB: Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin-5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 1995;92:12290-12294.
68. Gulbenkian AR, Egan RW, Fernandez X, Jones H, Kreutner W, Kung T, Payvandi F, Sullivan L, Zurcher JA, Watnick AS: Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am Rev Respir Dis 1992; 146:263-266.
69. Chand N, Harrison JE, Rooney S, Pillar J, Jakubicki R, Nolan K, Diamantis W, Sofia RD: Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: A therapeutic approach. Eur J Pharmacol 1992;211:121-123.
70. Van Oosterhout AJ, Ladenius AR, Savelkoul HF, Van Ark I, Delsman KC, Nijkamp FP: Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am. Rev. Respir. Dis. 1993;147:548-552.
71. Mause PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, Jones H, Watnick AS, Egan RW, Kreutner W, et al: Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993; 148:1623-1627.
72. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK III, Kreutner W, Egan RW, Chapman RW: Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-472.
73. Hamelmann E, Wahn U, Gelfand EW: Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int Arch Allergy Immunol 1999;118:90-94.
74. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI: IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity. 1996;4:15-24.
75. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
76. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS: Aeroallergen-induced eosinophilic inflammation, lung damage, and airway hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997;99:1329-1339.
77. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B-cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991;350:423-426.
78. Hamelmann E, Schwarze J, Vella AT, Marrack P, Gelfand EW: Development of eosinophilic airway inflammation and airway hyperresponsiveness in allergen sensitized B-cell deficient mice. Am J Respir Cell Mol Biol 1999, in press.
79. Hamelmann E, Vella AT, Oshiba A, Marrack P, Kappler JW, Gelfand EW: Allergic airway sensitization induces T-cell activation but not airway hyperresponsiveness in B-cell deficient mice. Proc Natl Acad Sci USA 1997;94:1350-1355.
80. Oshiba A, Hamelmann E, Takeda K, Bradley KL, Loader JE, Larsen GL, Gelfand EW: Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific IgE and IgG1 in mice. J Clin Invest 1996;97:1398-1408.
81. Henderson WR Jr, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochon Y, Jonas M, Christie PE, Harlan JM: Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:3083-3092.
82. Henderson WR Jr, Lewis DB, Albert RK, Zhang Y, Lamm WJ, Chiang GK, Jones F, Eriksen P, Tien YT, Jonas M, Chi EY: The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 1996;184:1483-1494.
83. Coyle AJ, Kohler G, Tsuyuki S, Brombacher F, Kopf M: Eosinophils are not required to induce airway hyperresponsiveness after nematode infection. Eur J Immunol 1998;28:2640-2647.
84. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS: A novel T cell-regulated mechanism modulating allergen-induced airway hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol. 1998; 161:1501-1509.
85. Schwarze J, Hamelmann E, Bradley K, Takeda K, Gelfand EW: Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen. J Clin Invest 1997;100:226-233.
86. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW: CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999; 162:4207-4211.
87. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Shultz LD, Lamers MC, Gelfand EW: IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol. 1999;162:2997-3004.
88. Corrigan CJ, Hamid Q, North J, Barkans J, Moqbel R, Durham S, Gemou-Engesaeth V, Kay AB: Peripheral blood CD4 but not CD8 T-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: Effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995;12:567-578.
89. Wallen N, Kita H, Weiler D, Gleich GJ: Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-3495.
90. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Tsuruoka N, Okudaira H: IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol 1995;7:449-457.
91. Mullarkey M: Immunosuppressive therapy for asthma. Allergy Proc 1995;16:81-84.
92. Nagai H, Yamaguchi S, Tanaka H, Inagaki N: Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. Int Arch Allergy Immunol 1995;108:189-195.
93. Nizankowska E, Soja J, Pinis G, Bochenek G, Sladek K, Domagala B, Pajak A, Szczeklik A: Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J 1995;8:1091-1099.
94. Sano T, Nakamura Y, Matsunaga Y, Takahashi T, Azuma M, Okano Y, Shimizu E, Ogushi F, Sone S, Ogura T: FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma. Eur Respir J 1995;8: 1473-1478.
95. Mori A, Suko M, Kaminuma O, Nishizaki Y, Nagahori T, Mikami T, Ohmura T, Hosino A, Asakura Y, Okudaira H: Enhanced production and gene expression of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription inhibitor. Adv Exp Med Biol 1996;409: 439-450.
96. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P: Essential role of nuclear factor kappa B in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998; 188:1739-1750.
97. Lack G, Bradley KL, Hamelmann E, Renz H, Loader JE, Leung DY, Larsen GL, Gelfand EW: Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-1439.
98. Schwarze J, Hamelmann E, Cieslewicz G, Tomkinson A, Joetham A, Bradley K, Gelfand EW: Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J Allergy Clin Immunol 1998;102:86-93.
99. Devos R, Plaetinck G, Cornelis S, Guisez Y, Van der Heyden J, Tavernier J: Interleukin-5 and its receptor: A drug target for eosinophilia associated with chronic allergic disease. J Leukoc Biol 1995;57:813-819.
100. Monahan J, Siegel N, Keith R, Caparon M, Christine L, Compton R, Cusik S, Hirsch J, Huynh M, Devine C, Polazzi J, Rangwala S, Tsai B, Portanova J: Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor. J Immunol 1997;159:4024-4034.